John Johnson Axogen, Inc. (AXGN) insider trading activity

AXGN Quotes by TradingView

John Johnson is Director of Axogen, Inc.. Currently has a direct ownership of 29,016 shares of AXGN, which is worth approximately $471,800. The most recent transaction as insider was on Sep 01, 2024, when has been sold 11,904 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29K
0% 3M change
349.23% 12M change
Total Value Held $471,800

JOHN JOHNSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2024
BUY
Exercise of conversion of derivative security
-
11,904 Added 29.09%
29,016 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
10,653 Added 38.37%
17,112 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
6,459 Added 50.0%
6,459 Common Stock

Also insider at

VSTM
Verastem, Inc. Healthcare
Director
XERS
Xeris Biopharma Holdings, Inc. Healthcare
Director
APLT
Applied Therapeutics Inc. Healthcare
Executive Chairman
SBBP
Strongbridge Biopharma plc
Chief Executive Officer
JJ

John Johnson

Director
Trevose, PA

Track Institutional and Insider Activities on AXGN

Follow Axogen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

News

Receive news related to Axogen, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AXGN